A detailed history of N Verses Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 2,200 shares of ABBV stock, worth $391,622. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,200
Previous 1,700 29.41%
Holding current value
$391,622
Previous $292 Million 49.0%
% of portfolio
0.2%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $81,920 - $99,665
500 Added 29.41%
2,200 $434 Million
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $263,143 - $307,292
1,700 New
1,700 $292 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.